EDUCATION

A.B. in physics and mathematics, 1948
Hamilton College

Ph.D. in neurophysiology, 1953
Johns Hopkins University

POSTDOC

University of London, 1953–1954

Cambridge University, 1954–1955

UK National Institute for Medical Research, 1955–1958

National Institutes of Health, 1958–1959

POSITIONS

Director of Biochemical Research, 1959–1967
Geigy Research Laboratories

Professor, 1968–1983
Yale University School of Medicine

Professor, 1983–
Director, Fisher Center for Alzheimer’s Disease Research, 1995–
The Rockefeller University

MEMBERSHIPS

National Academy of Sciences
American Academy of Arts and Sciences
American Philosophical Society
Foreign Member, Royal Swedish Academy of Sciences
Norwegian Academy of Science and Letters
Serbian Academy of Sciences and Arts

AWARDS

Dickson Prize, 1977

Pfizer Biomedical Research Award, 1986

3M Life Sciences Award, Federation of American Societies for Experimental Biology, 1987

William R. McAlpin, Jr., Award, National Mental Health Association, 1987

Bristol-Myers Award, 1989

National Academy of Sciences Award in the Neurosciences, 1991

Karl Spencer Lashley Prize, American Philosophical Society, 1993

Ralph W. Gerard Prize in Neuroscience, 1994

Thudichum Medal, Biochemical Society, 1996

Lieber Prize in Schizophrenia Research, 1996

Charles A. Dana Award, 1997

New York City Mayor’s Award for Excellence in Science and Technology, 1998

Ellison Medical Foundation Senior Scholar Award, 1999

Nobel Prize in Physiology or Medicine, 2000

Scientific Honoree, New York Academy of Medicine, 2002

Dart/NYU Biotechnology Achievement Award, 2010

Gold Medal, Karolinska Institute, 2010

SELECTED PUBLICATIONS

Svenningsson, P. et al. Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. Mol. Psychiatry 19, 962–964 (2014).

Tan, C.L. et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342, 1254–1258 (2013).

Svenningsson, P. et al. p11 and its role in depression and therapeutic responses to antidepressants. Nat. Rev. Neurosci. 14, 673–680 (2013).

Oh, Y.S. et al. SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152, 831–843 (2013).

Heiman, M. et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738–748 (2008).